yes they have - three phase 1b trials have commenced.
another phase 1 dose escalation about to commence.
which is amazing for a company with a market cap of $25m and $10m in the bank that is the lead ASX company in cell therapy in immuno-oncology
Chimeric: Media Thread, page-685
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $14.01M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.6¢ | $75.72K | 4.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 2822785 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 510000 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| CHM (ASX) Chart |